Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Clinical trial NCT02914314 · COMPLETED
Trial details
- NCT number
- NCT02914314
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-20
- Primary completion
- 2022-08-23
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.